IR-2023-001

IR-2023-001 is a preclinical-stage functional ingredient being developed by Dong-A Pharmaceutical for the improvement of gum and oral health. Categorized within the company's health functional food (HFF) pipeline, the agent is currently undergoing in vivo safety and efficacy evaluations. It is intended to support periodontal health maintenance, potentially through anti-inflammatory or protective effects on gum tissue, although its specific molecular target has not been publicly disclosed. As a functional ingredient, it is likely intended for use in specialized oral care products or dietary supplements rather than as a traditional prescription pharmaceutical.